Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?
about
The clinical toxicology of metamfetamineImpact of methamphetamine on infection and immunityNeurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamineRecurrent Syncope following Substance Abuse; a Case Report.Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction.Methamphetamine causes acute hyperthermia-dependent liver damageCritical role of insulin‑like growth factor binding protein‑5 in methamphetamine‑induced apoptosis in cardiomyocytes.Factors responsible for mortality variation in the United States: A latent variable analysis.Association of modifiable risk factors and left ventricular ejection fraction among hospitalized Native Hawaiians and Pacific Islanders with heart failure.Methamphetamine-associated cardiomyopathy.Peripheral ammonia as a mediator of methamphetamine neurotoxicityReport of methamphetamine use and cardiomyopathy in three patients.Acute myocardial infarction in young adults who abuse amphetamines.Risk factors associated with methamphetamine use and heart failure among native Hawaiians and other Pacific Island peoples.A comparison of echocardiographic findings in young adults with cardiomyopathy: with and without a history of methamphetamine abuse.Acute methamphetamine exposure inhibits cardiac contractile function.Ecstasy produces left ventricular dysfunction and oxidative stress in rats.National trends in psychostimulant-related deaths: 1999-2009.Psychostimulant-related deaths among former inmates.An unusual cause of breathlessness in a young man.Cross-national comparison of prenatal methamphetamine exposure on infant and early child physical growth: a natural experiment.Histopathological study of cardiac lesions in methamphetamine poisoning-related deaths.Neurobehavioral Effects from Developmental Methamphetamine Exposure.Methamphetamine-Associated Congestive Heart Failure: Increasing Prevalence and Relationship of Clinical Outcomes to Continued Use or Abstinence.Exposure to Amphetamines Leads to Development of Amphetamine Type Stimulants Associated Cardiomyopathy (ATSAC).Pneumomediastinum following Crystal Use: A Report of Two Cases.Methamphetamin abuse a new concern in Iran.Simultaneous thrombosis of the left anterior descending artery and the right coronary artery in a 34-year-old crystal methamphetamine abuser.Cardiovascular Complications of Acute Amphetamine Abuse: Cross-sectional study.Histopathological studies of cardiac lesions after an acute high dose administration of methamphetamine.Fluoxetine attenuates chronic methamphetamine-induced pulmonary arterial remodelling: possible involvement of serotonin transporter and serotonin 1B receptor.Higher defibrillation threshold in methamphetamine cardiomyopathy patients with implantable cardioverter-defibrillator.Relationship between KCNQ1 (LQT1) and KCNH2 (LQT2) gene mutations and sudden death during illegal drug use.
P2860
Q22305685-BE6B3975-ED5B-48FE-9DB9-C6369B9337A5Q26829217-88D7C1D1-10A9-44E5-861D-756F74DAF0FEQ30417935-A8AA9CB5-470F-4154-BB9C-5600D31D1A5EQ33168394-C65CC6A2-CFF3-4295-9923-F63F2332F1BDQ33906863-313837C5-967C-40CE-8716-5CCB960A33B3Q34286457-CCAB2063-69C3-4137-A44E-4238CAE99737Q34426884-0FE5AE20-C0C4-4F88-B816-14D01B1DC520Q34546989-E36374A5-9C77-476C-964D-497310FB99E4Q34738913-CEE6D0FC-24A2-4B32-8657-B9159713A461Q35057922-987AB0E3-ED7F-4B13-825F-EFD6BF522FB2Q36299507-5347B666-7D89-4D2E-9ABB-CD90CD315AC7Q36564458-C2A5596E-14D6-4651-B576-E78E1DD5E491Q36869525-1571618E-9D46-4F33-B3FB-B8106C037497Q37167529-AA9EDE15-C4E3-431E-9229-FD50C768D3FAQ37209357-10A8028A-F221-44AD-987C-D9AAE0D8A779Q37313644-6C86CC16-B576-4A30-854A-4ABA25FF6A85Q37318873-142445E3-9495-4EAD-8BE2-F85BC7BFBE24Q37422936-5424713D-5A4E-4FB8-8156-38A9B5A449B2Q37443482-B8967528-965B-4F1B-BE7F-AF192F3C00EBQ37523325-A01D891A-A835-474E-926A-91AEC6B3CFFFQ37627099-0756254D-DBE2-490C-BED5-8AB8EC1441A6Q37650985-7933C85A-64B7-4214-B8BF-622375E465C6Q38621196-62EB5786-CE64-41C1-9E6E-B712A157E3A4Q38667651-676DD15F-EEFE-4DEF-A1F7-77CF5FB9E962Q38963197-CFC281D7-3422-4EF6-94C0-F430545EAE9CQ40013936-728B3593-9B3B-4462-A7F7-FD55A928A7A7Q42078538-4BEC7A53-A244-48CA-889E-588D1E407BBEQ42135482-616E1ED7-2218-4BC0-9A5D-27B49AEF3B7BQ42138859-0663855D-6341-4EA7-90E9-803B9211B40CQ42143886-B271019D-5733-4624-8041-00FCE2F24712Q43485104-0A8C45B3-00BD-40EF-9C0A-78F708BB9C05Q47303210-19717FEA-E633-4101-A21B-F2FB2EC4FF8DQ55359476-571680B3-86A0-419C-BB64-C2CCD9D70DE5
P2860
Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?
@en
Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?
@nl
type
label
Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?
@en
Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?
@nl
prefLabel
Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?
@en
Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?
@nl
P2093
P2860
P356
P1476
Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?
@en
P2093
Irwin Schatz
Joseph Lindsay
Mevan Wijetunga
P2860
P304
P356
10.1081/CLT-120026521
P577
2003-01-01T00:00:00Z